[THE INVESTOR] On Oct. 19, Amicogen (092040) increased 5.15% to 51,000 won (US$45.41). It had declined 16.21% through the past month. Standard deviation, the volatility index for stock price, was 2.6% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSDAQ, as the monthly volatility of Amicogen was relatively expand, the stock price was stay at a low level with decline. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.2%. As high volatility and a bearish stock price trend, the return-on-risk recorded the worst value among its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -0.6, and thus the industrial comparison performance was not so good.
From Oct. 17, both institutions and foreigners were buying during the past two trading days. As a shareholding sum by investor group for the past four weeks, foreigners have sold 47,300 shares with maintenance of a selling position and institutions have sold 55,540 shares with a selling trend. However, during the same period, individuals have bought 102,840 shares with an increasing position.
| Cumulated shareholdings per investor group (1Mo) | Total shareholdings per investor group | |
![]() |
![]() |
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.




